This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: Similarly, 33.7% of Vioxx users reported increased range of motion in the first six months, compared to 4.4% of patients in the control group. This figure also increased to 60.3% of participants after they had been taking Vioxx for twelve to eighteen months, while only 6.8% of the control group reported increased range of motion. The study also indicates that Vioxx can have significant benefits in the reduction of colon polyps, and the benefit appears to increase the longer that Vioxx is taken. 3.8% of Vioxx participants report reduced colon polyps in the first six months; 7.5% after six to twelve months, and 17.3% of patients taking Vioxx for twelve to eighteen months report reduced colon polyps. When this data is compared to that of the control group, which remains fairly constant at around 2% of participants, the potential benefit of Vioxx for reducing colon polyps is clear....
View Full Document
- Fall '07
- Redox, Clinical trial, vioxx, colon polyps